Erratum

Erratum for the Research Article: “Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance” by J. M. Giltnane, K. E. Hutchinson, T. P. Stricker, L. Formisano, C. D. Young, M. V. Estrada, M. J. Nixon, L. Du, V. Sanchez, P. G. Ericsson, M. G. Kuba, M. E. Sanders, X. J. Mu, E. M. Van Allen, N. Wagle, I. A. Mayer, V. Abramson, H. Gόmez, M. Rizzo, W. Toy, S. Chandarlapaty, E. L. Mayer, J. Christiansen, D. Murphy, K. Fitzgerald, K. Wang, J. S. Ross, V. A. Miller, P. J. Stephens, R. Yelensky, L. Garraway, Y. Shyr, I. Meszoely, J. M. Balko, C. L. Arteaga

See allHide authors and affiliations

Science Translational Medicine  13 Feb 2019:
Vol. 11, Issue 479, eaaw7620
DOI: 10.1126/scitranslmed.aaw7620

In the Research Article “Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance,” the authors have provided additional competing interests, and the competing interests statements have been updated. The PDF and HTML (full text) have been corrected.

Navigate This Article